Literature DB >> 27858821

Cellular Therapy for Sepsis: A New Hope?

Perenlei Enkhbaatar1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27858821      PMCID： PMC5123745          DOI： 10.1097/CCM.0000000000002147

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  11 in total

1.  Drug for severe sepsis is withdrawn from market, fails to reduce mortality.

Authors:  Mike Mitka
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care.

Authors:  D C Angus; W T Linde-Zwirble; J Lidicker; G Clermont; J Carcillo; M R Pinsky
Journal:  Crit Care Med       Date:  2001-07       Impact factor: 7.598

Review 3.  The resolution of inflammation: Principles and challenges.

Authors:  Sarah E Headland; Lucy V Norling
Journal:  Semin Immunol       Date:  2015-04-22       Impact factor: 11.130

4.  Immunotherapy for sepsis--a new approach against an ancient foe.

Authors:  Richard S Hotchkiss; Steven Opal
Journal:  N Engl J Med       Date:  2010-07-01       Impact factor: 91.245

5.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

Review 6.  Current insights in sepsis: from pathogenesis to new treatment targets.

Authors:  W Joost Wiersinga
Journal:  Curr Opin Crit Care       Date:  2011-10       Impact factor: 3.687

Review 7.  Concise review: Mesenchymal stem cells for acute lung injury: role of paracrine soluble factors.

Authors:  Jae W Lee; Xiaohui Fang; Anna Krasnodembskaya; James P Howard; Michael A Matthay
Journal:  Stem Cells       Date:  2011-06       Impact factor: 6.277

8.  The sepsis seesaw: tilting toward immunosuppression.

Authors:  Richard S Hotchkiss; Craig M Coopersmith; Jonathan E McDunn; Thomas A Ferguson
Journal:  Nat Med       Date:  2009-05       Impact factor: 53.440

9.  microRNA-206 is involved in survival of hypoxia preconditioned mesenchymal stem cells through targeting Pim-1 kinase.

Authors:  You Zhang; Wei Lei; Weiya Yan; Xizhe Li; Xiaolin Wang; Zhenao Zhao; Jie Hui; Zhenya Shen; Junjie Yang
Journal:  Stem Cell Res Ther       Date:  2016-04-22       Impact factor: 6.832

10.  Hypoxic preconditioning potentiates the trophic effects of mesenchymal stem cells on co-cultured human primary hepatocytes.

Authors:  Harry H Qin; Céline Filippi; Song Sun; Sharon Lehec; Anil Dhawan; Robin D Hughes
Journal:  Stem Cell Res Ther       Date:  2015-12-01       Impact factor: 6.832
View more
  1 in total

Review 1.  New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Mol Aspects Med       Date:  2017-09-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.